Androgen Antagonists
"Androgen Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds which inhibit or antagonize the biosynthesis or actions of androgens.
Descriptor ID |
D000726
|
MeSH Number(s) |
D06.347.065 D27.505.696.399.450.065
|
Concept/Terms |
Anti-Androgen Effect- Anti-Androgen Effect
- Anti Androgen Effect
- Effect, Anti-Androgen
- Antiandrogen Effect
- Effect, Antiandrogen
- Antiandrogen Effects
- Effects, Antiandrogen
- Anti-Androgen Effects
- Anti Androgen Effects
- Effects, Anti-Androgen
|
Below are MeSH descriptors whose meaning is more general than "Androgen Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Androgen Antagonists".
This graph shows the total number of publications written about "Androgen Antagonists" by people in UAMS Profiles by year, and whether "Androgen Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2023 | 1 | 1 | 2 | 2022 | 0 | 2 | 2 | 2021 | 0 | 2 | 2 | 2015 | 1 | 0 | 1 | 2011 | 1 | 0 | 1 | 2010 | 2 | 1 | 3 | 2006 | 1 | 1 | 2 | 2005 | 0 | 1 | 1 | 2004 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Androgen Antagonists" by people in Profiles over the past ten years.
-
Goktas Aydin S, Kutlu Y, Muglu H, Aydin A, Acikgoz O, Hamdard J, Karci E, Bilici A, Olmez OF, Yildiz O. Predictive significance of inflammatory markers and mGPS in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. Cancer Chemother Pharmacol. 2024 01; 93(1):71-78.
-
Atiq M, Chandran E, Karzai F, Madan RA, Aragon-Ching JB. Emerging treatment options for prostate cancer. Expert Rev Anticancer Ther. 2023 06; 23(6):625-631.
-
Diao L, Nealon SW, Carpinito GP, Badkhshan S, Wolfe AR, Dropkin BM, Sanders SC, Hudak SJ, Morey AF. Presenting signs and symptoms of artificial urinary sphincter cuff erosion. Int Braz J Urol. 2022 Jul-Aug; 48(4):679-685.
-
Lee LS, Sim AYL, Ong CW, Yang X, Ng CCY, Liu W, Rajasegaran V, Lim AMS, Aslim EJ, Ngo NT, Khor LY, Kanesvaran R, Allen JCJ, Tay KJ, Yuen JSP, Chong TW, Ho SSH, Teh BT, Chua MLK. NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer. Prostate Cancer Prostatic Dis. 2022 Apr; 25(4):741-748.
-
Abghari-Gerst M, Armstrong WR, Nguyen K, Calais J, Czernin J, Lin D, Jariwala N, Rodnick M, Hope TA, Hearn J, Montgomery JS, Alva A, Reichert ZR, Spratt DE, Johnson TD, Scott PJH, Piert M. A Comprehensive Assessment of 68Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients. J Nucl Med. 2022 04; 63(4):567-572.
-
Westaby D, Viscuse PV, Ravilla R, de la Maza MLDF, Hahn A, Sharp A, de Bono J, Aparicio A, Fleming MT. Beyond the Androgen Receptor: The Sequence, the Mutants, and New Avengers in the Treatment of Castrate-Resistant Metastatic Prostate Cancer. Am Soc Clin Oncol Educ Book. 2021 Jun; 41:e190-e202.
-
Can?ado BL, Miranda LC, Madeira M, Farias ML. Importance of bone assessment and prevention of osteoporotic fracture in patients with prostate cancer in the gonadotropic hormone analogues use. Rev Col Bras Cir. 2015 Jan-Feb; 42(1):62-6.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|